SCANPHARM A/S: Financial statements 2023
CVR: 16279099
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
SCANPHARM A/S (CVR 16279099) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 22,519,429 and a net result of DKK -4,424,691 compared with DKK -5,954,451 the year before. That is an increase of 29.4% compared with the year before. Equity in the 2023 report amounted to DKK 1,500,000. The solvency ratio was 4.7%. The company had 44 employees in the financial year.
- Gross Profit
- DKK 22,519,429
- Profit/Loss
- DKK -4,424,691
- Equity
- DKK 1,500,000
- Total Assets
- DKK 31,601,519
- Employees
- 44
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 22.5 mio. | -4.4 mio. | 1.5 mio. | 44 |
| 2022 | - | 17.4 mio. | -6 mio. | 1.5 mio. | 41 |
| 2021 | - | 11.3 mio. | -10.9 mio. | 1.5 mio. | 40 |
| 2020 | - | 5.1 mio. | -18.9 mio. | 1.9 mio. | 40 |
| 2019 | - | 17.8 mio. | -4 mio. | 5.9 mio. | 42 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
SCANPHARM A/S has published its annual report for 2022. Gross profit came to DKK 17,399,136, and the net result was DKK -5,954,451.
About SCANPHARM A/S
SCANPHARM A/S is a Danish company of the type Aktieselskab based in Birkerød, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SCANPHARM A/S AF 1992 and A/S SCANPHARM AF 1992. The management consists of Andreas Bjørn Jensen. The board consists of Janus Doré Pagh (chair), Andreas Bjørn Jensen and Hanne Bjørn Jensen. The company is owned by CHLOPETHAN A/S and Peluli Holding ApS. The company has 42 employees (2026). In 2025, the company reported a gross profit of DKK 29,716,677 and a net result of DKK 962,722 compared with DKK 582,684 the year before. Equity in the 2025 report amounted to DKK 3,045,406.